BIOLASE, INC Quarterly Cost of Revenue in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Biolase, Inc quarterly/annual Cost of Revenue history and growth rate from Q2 2010 to Q2 2024.
  • Biolase, Inc Cost of Revenue for the quarter ending June 30, 2024 was $6.95M, a 15% decline year-over-year.
  • Biolase, Inc Cost of Revenue for the twelve months ending June 30, 2024 was $30.9M, a 12.6% decline year-over-year.
  • Biolase, Inc annual Cost of Revenue for 2023 was $32.4M, a 0.34% decline from 2022.
  • Biolase, Inc annual Cost of Revenue for 2022 was $32.6M, a 43.7% increase from 2021.
  • Biolase, Inc annual Cost of Revenue for 2021 was $22.7M, a 36.4% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $30.9M $6.95M -$1.22M -15% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $32.1M $6.8M -$335K -4.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $32.4M $9.97M -$488K -4.67% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $32.9M $7.18M -$2.39M -25% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $35.3M $8.17M +$1.07M +15.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $34.2M $7.13M +$1.69M +31.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $32.6M $10.5M +$2.95M +39.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $29.6M $9.57M +$4.88M +104% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $24.7M $7.09M +$2M +39.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $22.7M $5.44M +$62K +1.15% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $22.7M $7.5M +$587K +8.49% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-21
Q3 2021 $22.1M $4.69M +$424K +9.94% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $21.6M $5.09M +$3.1M +155% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $18.6M $5.38M +$1.95M +56.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $16.6M $6.92M +$1.15M +19.9% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-28
Q3 2020 $15.5M $4.27M -$1.41M -24.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $16.9M $2M -$3.27M -62.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $20.1M $3.43M -$3.37M -49.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $23.5M $5.77M -$1.67M -22.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-17
Q3 2019 $25.2M $5.68M -$1.32M -18.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $26.5M $5.27M -$2.58M -32.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $29.1M $6.8M -$183K -2.62% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $29.3M $7.43M -$1.59M -17.6% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-31
Q3 2018 $30.8M $7M -$956K -12% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $31.8M $7.85M -$62K -0.78% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $31.9M $6.99M +$66K +0.95% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $31.8M $9.02M +$662K +7.92% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-30
Q3 2017 $31.1M $7.95M +$327K +4.29% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $30.8M $7.91M -$246K -3.02% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 $31.1M $6.92M -$445K -6.04% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $31.5M $8.36M -$501K -5.66% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-08
Q3 2016 $32M $7.62M -$229K -2.92% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 $32.2M $8.15M -$14K -0.17% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $32.2M $7.37M -$279K -3.65% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $32.5M $8.86M +$730K +8.98% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 $31.8M $7.85M +$532K +7.27% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $31.3M $8.17M +$1.71M +26.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-01
Q1 2015 $29.6M $7.65M +$68K +0.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $29.5M $8.13M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-10
Q3 2014 $7.32M -$1.2M -14% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $6.46M -$2.23M -25.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $7.58M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-01
Q3 2013 $8.52M +$1.02M +13.5% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $8.69M +$870K +11.1% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q4 2012 $30.9M $9.05M +$1.44M +18.9% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-06
Q3 2012 $29.4M $7.5M -$243K -3.14% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $29.7M $7.82M +$1.35M +20.9% Apr 1, 2012 Jun 30, 2012 10-Q/A 2012-09-06
Q1 2012 $28.3M $6.51M +$791K +13.8% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $27.5M $7.61M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
Q3 2011 $7.74M +$3.31M +74.8% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $6.47M +$2.51M +63.2% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-06
Q1 2011 $5.72M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 $4.43M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 $3.96M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.